Megan Baumgart, MD
Medical Oncology · Rochester, NYNPI 1881896157
Payments from drug & device makers
Across 45 payments — averaging $11,799 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$384K
- Pfizer$124K
- Iovance Biotherapeutics, Inc.$10K
- Astrazeneca UK Limited$7K
- E.r. Squibb & Sons, L.L.C.$4K
- Beigene, Ltd.$2K
- plus $164 from 2 others
What the payments were for
- Consulting fees$5,03785%
- Travel & lodging$63011%
- Food & beverage$1703%
- Education$571%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $383,500 |
| Pfizer | 24 | $123,943 |
| Iovance Biotherapeutics, Inc. | 4 | $9,994 |
| Astrazeneca UK Limited | 2 | $7,497 |
| E.r. Squibb & Sons, L.L.C. | 9 | $4,222 |
| Beigene, Ltd. | 1 | $1,650 |
| AstraZeneca | 1 | $143 |
| Mirati Therapeutics, Inc. | 1 | $21 |
How this compares
$530,971 in reported general payments places this provider in the 60th percentile of 498 medical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 63 | $826 |
| Dexamethasone | 19 | $278 |
| Ondansetron Hcl | 51 | $199 |
| Levothyroxine Sodium | 32 | $149 |
| Gabapentin | 19 | $107 |
| Oxycodone Hcl | 21 | $100 |
| Prednisone | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Rochester
- Anthony MatoIthaca$40.3M
- Robert MotzerNew York$32.8M
- Alan HoNew York$32M
- Michael MorrisNew York$30.4M
- Matthew GalskyNew York$28.1M
- Wungki ParkNew York$25.5M
- Komal JhaveriNew York$22.3M
- Joshua RichterNew York$19.9M
- Jia RuanNew York$19.8M
- Andrea CercekNew York$17.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.